Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes

Annals of Neurology

Volumn 62, Issue 1, 2007, Pages 15-20

  Pradat, Pierre François ^a   Bruneteau, Gaelle ^a   Gonzalez De Aguilar, Jose Luis ^b,c   Dupuis, Luc ^b,c   Jokic, Natasa ^b,c   Salachas, François ^a   Le Forestier, Nadine ^a   Echaniz Laguna, Andoni ^b,c,d   Dubourg, Odile ^a   Hauw, Jean Jacques ^a   Tranchant, Christine ^d   Loeffler, Jean Philippe ^b,c   Meininger, Vincent ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN NOGO A;

ACCURACY; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; LOWER MOTOR NEURON SYNDROME; MALE; MOTOR NEURON DISEASE; MUSCLE BIOPSY; MUSCLE LEVEL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SYMPTOM; WESTERN BLOTTING;

ADULT; AGED; BIOPSY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; MUSCLE, SKELETAL; MYELIN PROTEINS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 34547765317     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21122     Document Type: Article

References (19)

1. Van Den Berg-Vos RM, Visser J, Franssen H, et al. Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain 2003;126:1036-1047.
2. World Federation of Neurology Research Committee Research Group on Neuromuscular Diseases. J Neurol Sci 1988;86:333-360.
3. Mitsumoto H, Chad DA, Pioro EP. The differential diagnosis of ALS. In: Mitsumoto H, Chad DA, Pioro EP, eds. Amyotrophic lateral sclerosis. Philadelphia: FA Davis Company, 1998:87-121.
4. Visser J, Van Den Berg-Vos RM, Franssen H, et al. Mimic syndromes in sporadic cases of progressive spinal muscular atrophy. Neurology 2002;58:1593-1596.
5. Schwab ME. Nogo and axon regeneration. Curr Opin Neurobiol 2004;14:118-124.
6. Dupuis L, Gonzalez de Aguilar JL, Di Scala F, et al. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol Dis 2002;10:358-365.
7. Jokic N, Gonzalez de Aguilar JL, Pradat PF, et al. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol 2005;57:553-556.
8. Jokic N, Gonzalez de Aguilar JL, Dimou L, et al. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep 2006;7:1162-1167.
9. Di Scala F, Dupuis L, Gaiddon C, et al. Tissue specificity and regulation of the N-terminal diversity of reticulon 3. Biochem J 2005;385:125-134.
10. Traynor BJ, Codd MB, Corr B, et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch Neurol 2000;57:1171-1176.
11. Ince PG, Evans J, Knopp M, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003;60:1252-1258.
12. Zoccolella S, Beghi E, Palagano G, et al. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J Neurol Sci 2006;250:45-49.
13. Kalra S, Arnold D. Neuroimaging in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:243-248.
14. Cudkowicz M, Qureshi M, Shefner J. Measures and markers in amyotrophic lateral sclerosis. Neurorx 2004;1:273-283.
15. Riviere M, Meininger V, Zeisser P, et al. An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole. Arch Neurol 1998;55:526-528.
16. Katz JS, Wolfe GI, Andersson PB, et al. Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology 1999;53:1071-1076.
17. Hu MT, Ellis CM, al Chalabi A, et al. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1998;65:950-951.
18. Fergani A, Dupuis L, Jokic N, et al. Reticulons as markers of neurological diseases: focus on amyotrophic lateral sclerosis. Neurodegener Dis 2005;2:185-194.
19. Pasinetti GM, Ungar LH, Lange DJ, et al. Identification of potential CSF biomarkers in ALS. Neurology 2006;66:1218-1222.